A 15 year old State-of-the-art Pharmaceuticals entity from Telangana,India is looking to acquire API manufacturers in India.

Posted By - Investment Banker

TARGET BRIEF

The company wishes to acquire a running, Profitable  API (preferably)manufacturing company with revenues between INR 150-800 Crores

About the Company-

Company is a vertically integrated pharmaceutical company accredited by DCGI,MOH(Turkey),USFDA,BPFK (Malaysia), MOH (UAE). Over the past 15 years, it has expanded its spectrum by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research. The Research Centre is supported by a team of 30 – 35 scientists who brings about 200 person-years of experience

Proposal

Dealsize IconDeal Size INR 1500 to 8000 Mn
Special Requirement: API manufacturing
Industry Icon

Industry

Pharmaceuticals

Subindustry Icon

Sub-Industry

API

Target Location

Pan India

Type

General & Beta Lactum

Product

Any

Export

Yes

Funding Sources

Cash,Fresh Debt,Fresh Equity

Synergies Sought

Manufacturing Strengths (Production/Operations), Access of resource in the industry

Deal Option

Complete Buyout,Minority

Business Operating Information

Industry Icon Industry: Pharmaceuticals

Industry Icon Sub-Industry: Integrated

Type

Location

Major Products

Major Customers

Division

Formulation type

Major Products

Financial Information

2018 (in INR) 2019 (in INR) 2020 (in INR) 2021 (in INR)
Sales N.D N.D N.D N.D
EBDITA N.D N.D N.D N.D
PAT N.D N.D N.D N.D
TANGIBLE NET WORTH N.D N.D N.D N.D
LONG TERM DEBT N.D N.D N.D N.D
TOTAL DEBT N.D N.D N.D N.D

Business Document

Other

CONTACT BUSINESS

If you are interested in connecting with business please send an Expression of Interest.

SHARE VIA
CONTACT DETAILS